SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3177)4/11/2007 9:30:07 AM
From: tom pope  Read Replies (1) of 7424
 
Just saw this:

April 11 (Reuters) - Cell Genesys Inc. (CEGE.O: Quote, Profile , Research) agreed to sell 10.8 million shares and warrants to buy 2.2 million shares for gross proceeds of $60 million. In a statement, the company said it intends to use the net proceeds from the offering to fund development of its product candidates, including ongoing late-stage trials of its product, GVAX immunotherapy for prostate cancer.

The offering is expected to close on April 16
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News